Neurobiologiako Laborategia
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaInstituto de Investigación Sanitaria Biogipuzkoa-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
2021
-
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease
Theranostics, Vol. 11, Núm. 13, pp. 6542-6559
2013
-
1–42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death
Translational Psychiatry, Vol. 3, Núm. 1
2012
-
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990